Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice

Brain Pathol. 2008 Jan;18(1):32-9. doi: 10.1111/j.1750-3639.2007.00094.x. Epub 2007 Oct 9.

Abstract

We and others have recently demonstrated that cognitive and physical stimulation in form of environmental enrichment reduces cerebral beta-amyloid (Abeta) deposition in transgenic mouse models of Alzheimer's disease. This effect was independent from amyloid precursor protein (APP) expression or processing and rather a consequence of enhanced clearance of Abeta. However, the detailed mechanisms remain unclear. In the present study, we show that environmental enrichment in TgCRND8 mice (carrying human APP(Swedish+Indiana)) affect the neurovascular unit by increased angiogenesis and differential regulation of Abeta receptor/transporter molecules, namely up-regulation of LRP1, ApoE and A2M as well as down-regulation of RAGE so that brain to blood Abeta clearance is facilitated. These results suggest a hitherto unknown effect of environmental enrichment counteracting the vascular dysfunction in Alzheimer diseased brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / prevention & control
  • Alzheimer Disease / therapy*
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Protein Precursor / genetics
  • Amyloid beta-Protein Precursor / metabolism
  • Animals
  • Carrier Proteins / metabolism
  • Cerebral Arteries / metabolism*
  • Cerebral Arteries / pathology
  • Cerebral Arteries / physiopathology
  • Cerebrovascular Circulation / physiology
  • Cerebrovascular Disorders / physiopathology
  • Cerebrovascular Disorders / prevention & control
  • Cerebrovascular Disorders / therapy*
  • Cricetinae
  • Disease Models, Animal
  • Environment Design*
  • Female
  • Gene Expression Regulation / physiology
  • Housing, Animal
  • Humans
  • Mice
  • Mice, Transgenic
  • Microcirculation / metabolism
  • Microcirculation / pathology
  • Microcirculation / physiopathology
  • Mitogen-Activated Protein Kinases / metabolism
  • Neovascularization, Physiologic
  • Treatment Outcome

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Carrier Proteins
  • Mok protein, mouse
  • Mitogen-Activated Protein Kinases